For most of this year, ASML has been treated as the most obvious AI infrastructure buy on the planet.

The thesis practically wrote itself. AI demands more chips. More chips demand more fabs. More fabs demand lithography machines. And there is exactly one company on earth that makes the lithography machine every advanced fab depends on.

Then ASML reported the best quarter in its history on July 15. Revenue up 21% year over year. Full-year guidance raised for the second time in 2026. Beat on every metric.

The stock fell 11%.

This week's focus is on ASML. The monopoly thesis is real and the numbers are extraordinary. But a monopoly on the most geopolitically contested technology in the world carries a cost the earnings headline is not capturing.

Missed Monday's look at Apple's all-time high and the one thing the market isn't saying about it? 🍎 Apple Hit An All-Time High. Here Is What Nobody Is Saying.

The key issue is that TSMC’s U.S. expansion may protect supply chains politically, but it also adds cost pressure. Reuters reported TSMC pledged another $100 billion investment in Arizona after pressure to bring more chipmaking to the U.S., while analysts expect advanced-chip prices may rise 8% to 10% in 2027 to help protect margins. In plain English, AI chips may stay in huge demand, but the cost of “made closer to home” could flow straight through to Nvidia, Apple, AMD, and Big Tech customers.

The Fool’s point is that Berkshire’s huge Treasury position is not just a defensive habit. With 67% of its $263 billion cash pile sitting in short-term Treasuries, Buffett is still being paid well to wait while keeping optionality for a major deal or market dislocation. The bigger message is classic Berkshire: when valuations look stretched, earning safe income while staying liquid can be more attractive than forcing money into expensive stocks.

This MarketBeat piece argues Microsoft’s wider AI infrastructure push could be a major validation moment for AMD. The market has long treated Nvidia as the default AI winner, but Microsoft’s use of AMD chips in Azure suggests hyperscalers want credible second-source options for AI compute. If AMD can prove performance, supply, and cost advantages at scale, the story shifts from “Nvidia alternative” to a more serious AI infrastructure growth platform.

The best assistants don't multitask their attention across a hundred tools. Neither does Catch. It's an AI agent that focuses on one thing — the admin work you'd rather not touch — and does it exceptionally well.

Scheduling, flights, restaurants, follow-ups, vendors, clients. You hand it over; Catch handles the back-and-forth and comes back with it done.

No context-switching. No dropped balls. Just your admin, quietly cleared — so your focus stays on the work only you can do.

Meet the agent built for admin, and it'll be ready to work before your next meeting.

Get started at catchagent.ai — and give your attention back to what matters.

Start now for free

ASML (ASML) reported Q2 net sales of €9.3 billion on July 15, beating estimates and raising full-year 2026 guidance to €43 billion to €45 billion, the second upgrade this year. Q3 guidance came in at €11 billion to €12 billion. Forty-four analysts rate the stock "Strong Buy" with an average 12-month price target of $2,116.

The stock fell 11% anyway.

The question this newsletter is here to examine is not whether ASML is a great business. It clearly is. The question is what that 11% drop is pricing that the earnings headline is not.

EUV, Extreme Ultraviolet lithography, is the process technology required to manufacture chips at 7 nanometers and below. Every advanced AI chip in existence runs on silicon made by a machine that only ASML produces. There is no second source, no viable alternative, and no country that has replicated it.

Those are not the margins of a competitive market. Q2 gross margin hit 54%, and management guided Q3 to 55% to 57%. Those are the margins of a company that has no competition and prices accordingly.

Order backlog sits at approximately €40 billion to €45 billion. That is more than a full year of revenue already signed before ASML sells another machine. Installed Base Management added €2.8 billion in Q2, layering a recurring service stream on top of new system sales.

JPMorgan has a $2,400 price target. Wells Fargo has $2,500. The analyst community is not concerned about the business. The market's 11% reaction was not about the business either.

China was approximately 49% of ASML's revenue in 2022. Today it is approximately 20%. Not because Chinese chipmakers stopped needing machines. Because the US, Netherlands, and Japan have been systematically restricting what ASML can sell there.

Here is the current state of that restriction:

What ASML can still sell to China:

What is already banned:

What the new US export control draft would add:

Not a minor adjustment. A potential removal of the last meaningful China revenue category.

Not because ASML's technology advantage is shrinking. Because the market it can sell into is being drawn smaller by three governments who have not finished drawing.

Here is the thing about owning an irreplaceable technology. The more irreplaceable it becomes, the more governments want to control who gets access to it.

The US, Netherlands, and Japan now coordinate export policy specifically around ASML in a way that has no precedent for any single commercial company in this industry. Every new restriction narrows the addressable market.

Every narrowing pushes Chinese companies to accelerate domestic alternatives. Shanghai Micro Electronics Equipment is investing in domestic DUV technology precisely because Chinese chipmakers can see where this trajectory ends. Not because they expect to match EUV. Because they want to stop depending on a machine three governments are actively weaponizing.

The monopoly that made ASML indispensable has made it the most politically managed technology sale in the world.

ASML was trading around $1,800 heading into the July 15 earnings release, near the top of a range it had held for months. After the 11% drop, it sits near $1,768 as of this writing. What is notable is that the stock stabilized rather than continued lower. That says the market is adjusting a risk premium, not abandoning the thesis entirely.

The nearest support is around $1,760, and below that the 50-day trendline sits near $1,707. If $1,760 holds and the export control draft does not advance, the path back toward $1,813 and above is intact. If $1,760 breaks, the market is pricing something more permanent than a temporary China disruption, and the next meaningful floor is considerably lower.

This is the single most important near-term variable in the ASML thesis.

The US has been pressing the Netherlands to extend its export restrictions to DUV immersion systems, the last category China can currently still buy. A formal Dutch announcement would remove approximately 20% of ASML's current revenue in the following 12 to 18 months. Watch for any statement from The Hague on export license policy, or any ASML management commentary on China backlog execution timelines on the next earnings call.

ASML guided Q3 to €11 billion to €12 billion in net sales. A print above €11.5 billion confirms non-China AI demand is absorbing any China disruption. A print at the low end raises the question of whether China-deferred shipments padded the guidance in a way that becomes a Q4 problem. The Q3 revenue number, reported in October, is the most important single data point for this thesis over the next 90 days.

ASML's forward order flow is directly tied to how aggressively its largest customers are building fab capacity. I covered ASML's biggest customer just last Friday, and the demand picture is strong: Watch for TSMC and Samsung capex guidance updates in the second half of 2026 as the leading indicator for ASML order intake into 2027.

Shanghai Micro Electronics Equipment is developing domestic DUV alternatives with Chinese government backing. This is not an imminent EUV threat. It is a long-term threat to the assumption that China will permanently need ASML's DUV machines. Watch for Chinese government announcements on domestic semiconductor equipment milestones, because credible progress changes the long-term China revenue ceiling in a way no export restriction decision can undo.

The $1,800 level is the pre-earnings base that collapsed on July 15. A close back above it on meaningful volume, without a specific forcing news event, signals that the market has processed the China export control risk and reaffirmed AI demand as the dominant variable. That is the clearest entry signal this stock can give right now. Until it happens, buyers at $1,768 are accepting an unresolved political variable alongside one of the most extraordinary businesses in the semiconductor industry.

ASML is a genuinely extraordinary business. There is no version of this analysis where I doubt what the company has built.

Here is the problem at $1,768.

The market did not sell ASML because the earnings disappointed. It sold because the earnings proved exactly what governments are trying to restrict. ASML's monopoly is working so well that its sales policy is now a trilateral foreign policy decision between the US, Netherlands, and Japan. That is not a temporary condition.

ASML is worth owning. The question is whether it is worth owning at a price that requires export controls to stay where they are. They are not staying where they are.

Opening entities in every country can be slow, expensive, and hard to scale.

That's why more companies are using EOR to hire globally faster.

See how Oyster helps teams hire, pay, and support talent in 180+ countries while staying compliant along the way.

Get all the answers

Great businesses and great entries are not the same thing.

ASML reported the best quarter in its history on July 15. The stock fell 11%. That should tell you something about this investing moment: the market is not just pricing businesses anymore. It is pricing the political conditions around businesses.

Owning ASML at $1,768 means owning both the EUV monopoly and the export control negotiation happening around it. Those are very different things to be paying for.

Know what you are actually buying before you decide whether the price is right.

If this week's ASML deep dive sharpened how you see the monopoly trade, send it to one friend who is still buying the earnings headline.